KIORA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
KIORA PHARMACEUTICALS, INC. (KPRX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 418.15 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-03-25
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 418.15K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 161.30K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 90.38K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number as first filed 812.95K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 84.75K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number as first filed |
|---|---|---|
| 2025-12-31 | 418.15K shares 10-K · filed 2026-03-25 | |
| 2024-12-31 | 161.30K shares 10-K · filed 2026-03-25 | |
| 2023-12-31 | 90.38K shares 10-K · filed 2025-03-25 | 812.95K shares 10-K · filed 2024-03-25 |
| 2022-12-31 | 84.75K shares 10-K · filed 2024-03-25 | |
| 2021-12-31 | 12.95K shares 10-K · filed 2023-03-23 | 515.92K shares 10-K · filed 2022-04-15 |
| 2021-09-30 | 472.05K shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 377.36K shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 370.36K shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 246.89K shares 10-K/A · filed 2022-07-07 | |
| 2020-09-30 | 246.89K shares 10-Q · filed 2021-11-15 | |
| 2020-06-30 | 246.89K shares 10-Q · filed 2021-08-12 | |
| 2020-03-31 | 237.69K shares 10-Q · filed 2021-05-12 | |
| 2019-12-31 | 174.18K shares 10-K · filed 2020-03-04 | |
| 2019-09-30 | 180.21K shares 10-Q · filed 2020-11-09 | |
| 2019-06-30 | 185.08K shares 10-Q · filed 2020-08-06 | 2.78M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 185.08K shares 10-Q · filed 2020-05-06 | |
| 2018-09-30 | 145.75K shares 10-Q · filed 2019-11-07 | |
| 2018-06-30 | 2.11M shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |